Skip to main content
Erschienen in: Annals of Nuclear Medicine 2/2020

01.02.2020 | Review Article

Diagnosis of cardiac sarcoidosis: an era of paradigm shift

verfasst von: Apurva Sharma, David R. Okada, Harout Yacoub, Jonathan Chrispin, Sabahat Bokhari

Erschienen in: Annals of Nuclear Medicine | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Cardiac sarcoidosis is a granulomatous disease that may affect any organ, including the heart. Diagnosis of cardiac sarcoidosis is challenging, given the varied and non-specific clinical presentation and limited sensitivity and specificity of available diagnostic tests. With the growing interest and developments in imaging techniques, cardiac magnetic resonance imaging (CMR) and positron emission tomography (PET) have emerged as important tools in the diagnostic evaluation of patients with suspected cardiac sarcoidosis. These modalities have been given increasing emphasis in successive published diagnostic guidelines for CS. This review will provide an update on the recent paradigm shift in diagnostic guidelines for cardiac sarcoidosis, with a focus on the advanced cardiac imaging modalities and their developed role in clinical practice.
Literatur
1.
Zurück zum Zitat Iannuzzi MC, Fontana JR. Sarcoidosis: clinical presentation, immunopathogenesis and therapeutics. JAMA. 2011;305:391–9.CrossRef Iannuzzi MC, Fontana JR. Sarcoidosis: clinical presentation, immunopathogenesis and therapeutics. JAMA. 2011;305:391–9.CrossRef
2.
Zurück zum Zitat Bernstein M, Konzlemann F, Siddlik D. Boeck’s Sarcoid: report of a case with visceral involvement. Arch Intern Med. 1929;44:721–34.CrossRef Bernstein M, Konzlemann F, Siddlik D. Boeck’s Sarcoid: report of a case with visceral involvement. Arch Intern Med. 1929;44:721–34.CrossRef
3.
Zurück zum Zitat Hillerdal O., Niou E., Osterman K.Sarcoidosis. Epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis. 1984;130:29–32 Hillerdal O., Niou E., Osterman K.Sarcoidosis. Epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis. 1984;130:29–32
4.
Zurück zum Zitat Rybicki BA, Major M, Popovich J Jr, et al. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997;145:234–41.CrossRef Rybicki BA, Major M, Popovich J Jr, et al. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997;145:234–41.CrossRef
5.
Zurück zum Zitat Longcope WT, Freiman DG. A study of sarcoidosis; based on a combined investigation of 160 cases including 30 autopsies from The Johns Hopkins Hospital and Massachusetts General Hospital. Medicine (Baltimore). 1952;31(1):1–132.CrossRef Longcope WT, Freiman DG. A study of sarcoidosis; based on a combined investigation of 160 cases including 30 autopsies from The Johns Hopkins Hospital and Massachusetts General Hospital. Medicine (Baltimore). 1952;31(1):1–132.CrossRef
6.
Zurück zum Zitat Roberts WC, McAllister HA Jr, Ferrans VJ. Sarcoidosis of the heart: a clinicopathologic study of 35 necropsy patients (group I) and review of 78 previously described necropsy patients (group II). Am J Med. 1977;63:86–108.CrossRef Roberts WC, McAllister HA Jr, Ferrans VJ. Sarcoidosis of the heart: a clinicopathologic study of 35 necropsy patients (group I) and review of 78 previously described necropsy patients (group II). Am J Med. 1977;63:86–108.CrossRef
7.
Zurück zum Zitat Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet. 2003;361:1111–8.CrossRef Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet. 2003;361:1111–8.CrossRef
8.
Zurück zum Zitat Hiraga Y. An epidemiological study of clustering of sarcoidosis cases. Nippon Rinsho. 1994;52:1438–42.PubMed Hiraga Y. An epidemiological study of clustering of sarcoidosis cases. Nippon Rinsho. 1994;52:1438–42.PubMed
9.
Zurück zum Zitat Edmondstone WM. Sarcoidosis in nurses: is there an association? Thorax. 1988;43:342–3.CrossRef Edmondstone WM. Sarcoidosis in nurses: is there an association? Thorax. 1988;43:342–3.CrossRef
10.
Zurück zum Zitat Hennessy TH, Ballard DJ, DeRemee RA, et al. The influence of diagnostic access bias on the epidemiology of sarcoidosis: a population-based study in Rochester, Minnesota, 1935–1984. J Clin Epidemiol. 1988;44:565–70.CrossRef Hennessy TH, Ballard DJ, DeRemee RA, et al. The influence of diagnostic access bias on the epidemiology of sarcoidosis: a population-based study in Rochester, Minnesota, 1935–1984. J Clin Epidemiol. 1988;44:565–70.CrossRef
11.
Zurück zum Zitat Birnie DH, Nery PB, Ha AC, et al. Cardiac Sarcoidosis. J Am Coll Cardiol. 2016;68(4):11–21.CrossRef Birnie DH, Nery PB, Ha AC, et al. Cardiac Sarcoidosis. J Am Coll Cardiol. 2016;68(4):11–21.CrossRef
12.
Zurück zum Zitat Nery PB, Beanlands RS, Nair GM, et al. Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults. J Cardiovasc Electrophysiol. 2014;25(8):875–81.CrossRef Nery PB, Beanlands RS, Nair GM, et al. Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults. J Cardiovasc Electrophysiol. 2014;25(8):875–81.CrossRef
13.
Zurück zum Zitat Kandolin R, Lehtonen J, Airaksinen J, et al. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation. 2015;131(7):624–32.CrossRef Kandolin R, Lehtonen J, Airaksinen J, et al. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation. 2015;131(7):624–32.CrossRef
14.
Zurück zum Zitat Yazaki Y, Isobe M, Hiroe M, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol. 2001;88(9):1006–100.CrossRef Yazaki Y, Isobe M, Hiroe M, et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol. 2001;88(9):1006–100.CrossRef
15.
Zurück zum Zitat Guideline for Diagnosis of Cardiac Sarcoidosis: Study Report on Diffuse Pulmonary Diseases. Tokyo Japan: Ministry of Health, Labour and Welfare, 1993:23–4 Guideline for Diagnosis of Cardiac Sarcoidosis: Study Report on Diffuse Pulmonary Diseases. Tokyo Japan: Ministry of Health, Labour and Welfare, 1993:23–4
16.
Zurück zum Zitat Diagnostic standard and guidelines for sarcoidosis. Jpn J Sarcoidosis Granulomatous Disord. 2007;27:89–102. Diagnostic standard and guidelines for sarcoidosis. Jpn J Sarcoidosis Granulomatous Disord. 2007;27:89–102.
17.
Zurück zum Zitat Patel MR, Cawley PJ, MD, Heitner JF et al. Detection of myocardial damage in patients with sarcoidosis. Circulation. 2009; 120(20):1969–1977.CrossRef Patel MR, Cawley PJ, MD, Heitner JF et al. Detection of myocardial damage in patients with sarcoidosis. Circulation. 2009; 120(20):1969–1977.CrossRef
18.
Zurück zum Zitat Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11:1305–23.CrossRef Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11:1305–23.CrossRef
19.
Zurück zum Zitat Judson MA, Costabel U, Drent M, et al. The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis. 2014;31:19–27.PubMed Judson MA, Costabel U, Drent M, et al. The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis. 2014;31:19–27.PubMed
20.
Zurück zum Zitat Terasaki F, Yoshinaga K. New Guidelines for the diagnosis of Cardiac sarcoidosis in Japan. Ann Nucl Cardiol. 2017;3:42–5.CrossRef Terasaki F, Yoshinaga K. New Guidelines for the diagnosis of Cardiac sarcoidosis in Japan. Ann Nucl Cardiol. 2017;3:42–5.CrossRef
21.
Zurück zum Zitat Chareonthaitawee P, Beanlands RS, Chen W, et al. Joint SNMMI–ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Cardiol. 2017;24:1741.CrossRef Chareonthaitawee P, Beanlands RS, Chen W, et al. Joint SNMMI–ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Cardiol. 2017;24:1741.CrossRef
22.
Zurück zum Zitat Kumita S, Yoshinaga K, Miyagawa M, et al. Recommendations for 18-Fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac sarcoidosis-2018 update: Japanese Society of Nuclear Cardiology recommendations. J Nucl Cardiol. 2019. 10.1007/s12350–019–01755–3. [Epub ahead of print] Kumita S, Yoshinaga K, Miyagawa M, et al. Recommendations for 18-Fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac sarcoidosis-2018 update: Japanese Society of Nuclear Cardiology recommendations. J Nucl Cardiol. 2019. 10.1007/s12350–019–01755–3. [Epub ahead of print]
23.
Zurück zum Zitat Judson MA. The Clinical Features of Sarcoidosis: A Comprehensive Review. Clinic Rev Allerg Immunol. 2015;49:63.CrossRef Judson MA. The Clinical Features of Sarcoidosis: A Comprehensive Review. Clinic Rev Allerg Immunol. 2015;49:63.CrossRef
24.
Zurück zum Zitat Judson MA. The diagnosis of sarcoidosis. Curr Opin Pulm Med.2019. 10.1097/MCP.0000000000000596. [Epub ahead of print] Judson MA. The diagnosis of sarcoidosis. Curr Opin Pulm Med.2019. 10.1097/MCP.0000000000000596. [Epub ahead of print]
25.
Zurück zum Zitat Kim JS,BS, Judson MA, Donnino R, et al. Cardiac sarcoidosis. Am Heart J. 2009;157(1):9–21.CrossRef Kim JS,BS, Judson MA, Donnino R, et al. Cardiac sarcoidosis. Am Heart J. 2009;157(1):9–21.CrossRef
26.
Zurück zum Zitat Chapelon-Abric C, de Zuttere D, Duhaut P. Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine. 2004;83(6):315–34.CrossRef Chapelon-Abric C, de Zuttere D, Duhaut P. Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine. 2004;83(6):315–34.CrossRef
27.
Zurück zum Zitat Nagao S, Watanabe H, Sobue Y, et al. Electrocardiographic abnormalities and risk of developing cardiac events in extracardiac sarcoidosis. Int J Cardiol. 2015;189:1–5.CrossRef Nagao S, Watanabe H, Sobue Y, et al. Electrocardiographic abnormalities and risk of developing cardiac events in extracardiac sarcoidosis. Int J Cardiol. 2015;189:1–5.CrossRef
28.
Zurück zum Zitat Murtagh G, Laffin LJ, Patel KV, et al. Improved detection of myocardial damage in sarcoidosis using longitudinal strain in patients with preserved left ventricular ejection fraction. Echocardiography. 2016;33:1344–52.CrossRef Murtagh G, Laffin LJ, Patel KV, et al. Improved detection of myocardial damage in sarcoidosis using longitudinal strain in patients with preserved left ventricular ejection fraction. Echocardiography. 2016;33:1344–52.CrossRef
29.
Zurück zum Zitat Kinney EL, Caldwell JW. Do thallium myocardial perfusion scan abnormalities predict survival in sarcoid patients without cardiac symptoms? Angiology. 1990;41(7):573–6.CrossRef Kinney EL, Caldwell JW. Do thallium myocardial perfusion scan abnormalities predict survival in sarcoid patients without cardiac symptoms? Angiology. 1990;41(7):573–6.CrossRef
30.
Zurück zum Zitat Okayama K, Kurata C, Tawarahara K, et al. Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in Cardiac Sarcoidosis. Chest. 1995;107:330–4.CrossRef Okayama K, Kurata C, Tawarahara K, et al. Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in Cardiac Sarcoidosis. Chest. 1995;107:330–4.CrossRef
31.
Zurück zum Zitat Nakazawa A, Ikeda K, Ito Y, et al. Usefulness of dual Ga-67 and Tc-99m-Sestamibi single-photon-emission CT scanning in the diagnosis of cardiac sarcoidosis. Chest. 2004;126(4):1372–6.CrossRef Nakazawa A, Ikeda K, Ito Y, et al. Usefulness of dual Ga-67 and Tc-99m-Sestamibi single-photon-emission CT scanning in the diagnosis of cardiac sarcoidosis. Chest. 2004;126(4):1372–6.CrossRef
32.
Zurück zum Zitat Bennett MK, Gilotra NA, Harrington C, et al. Evaluation of the role of endomyocardial biopsy in 851 patients with unexplained heart failure from 2000–2009. Cir Heart Fail. 2013;6:676–84.CrossRef Bennett MK, Gilotra NA, Harrington C, et al. Evaluation of the role of endomyocardial biopsy in 851 patients with unexplained heart failure from 2000–2009. Cir Heart Fail. 2013;6:676–84.CrossRef
33.
Zurück zum Zitat Liang JJ, Hebl VB, DeSimone CV, et al. Electrogram guidance: a method to increase the precision and diagnostic yield of endomyocardial biopsy for suspected cardiac sarcoidosis and myocarditis. JACC Heart Fail. 2014;2(5):466–73.CrossRef Liang JJ, Hebl VB, DeSimone CV, et al. Electrogram guidance: a method to increase the precision and diagnostic yield of endomyocardial biopsy for suspected cardiac sarcoidosis and myocarditis. JACC Heart Fail. 2014;2(5):466–73.CrossRef
34.
Zurück zum Zitat Kandolin R, Lehtonen J, Graner M, et al. Diagnosing isolated cardiac sarcoidosis. J Intern Med. 2011;270(5):461–8.CrossRef Kandolin R, Lehtonen J, Graner M, et al. Diagnosing isolated cardiac sarcoidosis. J Intern Med. 2011;270(5):461–8.CrossRef
35.
Zurück zum Zitat Youssef G, Leung E, Mylonas I, et al. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and meta-analysis including the Ontario experience. J Nucl Med. 2012;53(2):241–8.CrossRef Youssef G, Leung E, Mylonas I, et al. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and meta-analysis including the Ontario experience. J Nucl Med. 2012;53(2):241–8.CrossRef
36.
Zurück zum Zitat Patel MR, Cawley PJ, Heitner JF, et al. Detection of myocardial damage in patients with sarcoidosis. Circulation. 2009;120:1969–77.CrossRef Patel MR, Cawley PJ, Heitner JF, et al. Detection of myocardial damage in patients with sarcoidosis. Circulation. 2009;120:1969–77.CrossRef
37.
Zurück zum Zitat Kouranos V, Tzelepis GE, Rapti A, et al. Complementary role of CMR to conventional screening in the diagnosis and prognosis of cardiac sarcoidosis. J Am Coll Cardiol Img. 2017;10:1437–47.CrossRef Kouranos V, Tzelepis GE, Rapti A, et al. Complementary role of CMR to conventional screening in the diagnosis and prognosis of cardiac sarcoidosis. J Am Coll Cardiol Img. 2017;10:1437–47.CrossRef
38.
Zurück zum Zitat Skali H, Schulman AR, Dorbala S. 18-F-FDG PET/CT for the assessment of myocardial sarcoidosis. Curr Cardiol Rep. 2013;15:370.CrossRef Skali H, Schulman AR, Dorbala S. 18-F-FDG PET/CT for the assessment of myocardial sarcoidosis. Curr Cardiol Rep. 2013;15:370.CrossRef
39.
Zurück zum Zitat Yamagishi H, Shirai N, Takagi M, et al. Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET. J Nucl Med. 2003;44(7):1030–6.PubMed Yamagishi H, Shirai N, Takagi M, et al. Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET. J Nucl Med. 2003;44(7):1030–6.PubMed
40.
Zurück zum Zitat Osborne MT, Hulten EA, Singh A, et al. Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis. J Nucl Cardiol. 2014;21:166–74.CrossRef Osborne MT, Hulten EA, Singh A, et al. Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis. J Nucl Cardiol. 2014;21:166–74.CrossRef
41.
Zurück zum Zitat Wicks EC, Menezes LJ, Barnes A, et al. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis. Eur Heart J Cardiovasc Imaging. 2018;19(7):757–67.CrossRef Wicks EC, Menezes LJ, Barnes A, et al. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis. Eur Heart J Cardiovasc Imaging. 2018;19(7):757–67.CrossRef
42.
Zurück zum Zitat Vita T, Okada DR, Veillet-Chowdhury M, et al. Complimentary value of cardiac magnetic resonance imaging and positron emission tomography/computed tomography in the assessment of cardiac sarcoidosis. Circ Cardiovasc Imaging. 2018;11:e007030.CrossRef Vita T, Okada DR, Veillet-Chowdhury M, et al. Complimentary value of cardiac magnetic resonance imaging and positron emission tomography/computed tomography in the assessment of cardiac sarcoidosis. Circ Cardiovasc Imaging. 2018;11:e007030.CrossRef
Metadaten
Titel
Diagnosis of cardiac sarcoidosis: an era of paradigm shift
verfasst von
Apurva Sharma
David R. Okada
Harout Yacoub
Jonathan Chrispin
Sabahat Bokhari
Publikationsdatum
01.02.2020
Verlag
Springer Singapore
Erschienen in
Annals of Nuclear Medicine / Ausgabe 2/2020
Print ISSN: 0914-7187
Elektronische ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-019-01431-z

Weitere Artikel der Ausgabe 2/2020

Annals of Nuclear Medicine 2/2020 Zur Ausgabe

Acknowledgment to Reviewers

Acknowledgment to Reviewers